Tribeca Skin Center brings back its hot takes series with topical peptides in skincare as the subject and invites viewers to weigh in.
Recap by typeshit. Post by @tribecaskincenter on Instagram.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A search result from Polskie Radio on oral semaglutide and weight loss, with no details given beyond the question itself.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
The endocrinologist takes on the growing habit of taking GLP-1 drugs in small doses, in a piece written for Firstpost.
Piotr Alvarez and Nitish Sharma cover flow rate, temperature, dwell volume and TFA levels, and why robustness testing decides whether a method transfers cleanly.
Loading…